Evidence map›Paper›PMID 34502019›Full record

ReviewInternational journal of molecular sciences2021

Nerve Growth Factor: A Potential Therapeutic Target for Lung Diseases.

Piaoyang Liu, Shun Li, Liling Tang

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. The Role of the Nervous System in Lung Disease.Current neurology and neuroscience reports · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Neurotrophins: Expression of Brain-Lung Axis Development.International journal of molecular sciences · 2023
    Review
  13. Review
  14. Article
  15. Significance of Singlet Oxygen Molecule in Pathologies.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Piaoyang LiuKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.ORCID 0000-0002-5923-5926
Shun LiDepartment of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Chengdu 610500, China.ORCID 0000-0001-9063-2965
Liling TangKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.ORCID 0000-0001-6640-0857
Chongqing University · CNChengdu Medical College · CN

Funding

Chengdu Medical College Research Foundation KYPY-20-01graduate scientific research and innovation foundation of Chongqing, China CYB20069National Natural Science Foundation of China No. 82002909
6 · The paper itself

Abstract

The lungs play a very important role in the human respiratory system. However, many factors can destroy the structure of the lung, causing several lung diseases and, often, serious damage to people's health. Nerve growth factor (NGF) is a polypeptide which is widely expressed in lung tissues. Under different microenvironments, NGF participates in the occurrence and development of lung diseases by changing protein expression levels and mediating cell function. In this review, we summarize the functions of NGF as well as some potential underlying mechanisms in pulmonary fibrosis (PF), coronavirus disease 2019 (COVID-19), pulmonary hypertension (PH), asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. Furthermore, we highlight that anti-NGF may be used in future therapeutic strategies.

Indexed as

Airway RemodelingAsthmaCOVID-19COVID-19 Drug TreatmentHumansHypertension, PulmonaryLungLung NeoplasmsMolecular Targeted TherapyNerve Growth FactorPulmonary Disease, Chronic ObstructivePulmonary FibrosisSignal TransductionNerve Growth FactorNGF protein, humancoronavirus disease 2019lungnerve growth factorpathway

Identifiers

PMID34502019
PMCPMC8430922
OpenAlexW3194351169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.